Candyce Kroenke to Receptor, ErbB-2
This is a "connection" page, showing publications Candyce Kroenke has written about Receptor, ErbB-2.
Connection Strength
0.167
-
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024 Jun 13; 26(1):101.
Score: 0.060
-
The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women's Health Initiative. Breast Cancer Res Treat. 2020 Apr; 180(3):747-757.
Score: 0.045
-
Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
Score: 0.032
-
Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
Score: 0.030